Published in Medical Patent Law Weekly, February 27th, 2008
Since its inception 13 years ago CryoCath has been, and continues to be the clear leader in innovation in the field of cryotherapy devices with cardiac applications and will continue to vigorously enforce its patent rights. CryoCath owns over 100 issued patents world-wide and has more than 100 patent applications pending. In the last five years, CryoCath has filed over 140 patent applications. Many of CryoCath's pending applications are expected to issue between 2008 and 2010, continuing to strengthen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.